Wei-Dong Wei

527 total citations
12 papers, 419 citations indexed

About

Wei-Dong Wei is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wei-Dong Wei has authored 12 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wei-Dong Wei's work include Breast Cancer Treatment Studies (4 papers), Breast Lesions and Carcinomas (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Wei-Dong Wei is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Breast Lesions and Carcinomas (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Wei-Dong Wei collaborates with scholars based in China, Switzerland and United States. Wei-Dong Wei's co-authors include Li-kun Chen, Zhuo-Jia Chen, Hao Liu, Xiangling Yang, Jun Du, Hongsheng Wang, Yin-duo Zeng, Fei Xu, Li Zhang and Ni He and has published in prestigious journals such as European Journal of Cancer, Oncotarget and Journal of Molecular Medicine.

In The Last Decade

Wei-Dong Wei

12 papers receiving 413 citations

Peers

Wei-Dong Wei
Catherine J. Kennedy Australia
Yaning He China
Shin Takayama Japan
Min‐Sun Jin South Korea
Carla Strina Italy
Anne Patsouris France
Shuiping Gao China
C. P. Carden United Kingdom
Sarah Croessmann United States
Leighton C. Stein United States
Catherine J. Kennedy Australia
Wei-Dong Wei
Citations per year, relative to Wei-Dong Wei Wei-Dong Wei (= 1×) peers Catherine J. Kennedy

Countries citing papers authored by Wei-Dong Wei

Since Specialization
Citations

This map shows the geographic impact of Wei-Dong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Dong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Dong Wei more than expected).

Fields of papers citing papers by Wei-Dong Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei-Dong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Dong Wei. The network helps show where Wei-Dong Wei may publish in the future.

Co-authorship network of co-authors of Wei-Dong Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Wei-Dong Wei. A scholar is included among the top collaborators of Wei-Dong Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei-Dong Wei. Wei-Dong Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Li, Yan, Bo Chen, Yong Du, et al.. (2017). Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis. Journal of Molecular Medicine. 95(8). 873–886. 68 indexed citations
2.
Xie, Zeming, Zhe-Yu Hu, Peng Liu, et al.. (2017). Survival outcomes of patients with lobular carcinoma in situ who underwent bilateral mastectomy or partial mastectomy. European Journal of Cancer. 82. 6–15. 7 indexed citations
3.
Chen, Zhuo-Jia, Wei Wei, Hao Liu, et al.. (2016). Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF‐κB signals. Molecular Oncology. 10(6). 775–788. 62 indexed citations
4.
He, Ni, Yanan Kong, Ning Lv, et al.. (2015). The utility of breast cone-beam computed tomography, ultrasound, and digital mammography for detecting malignant breast tumors: A prospective study with 212 patients. European Journal of Radiology. 85(2). 392–403. 58 indexed citations
5.
Chen, Zhuo-Jia, Hao Liu, Wei-Dong Wei, et al.. (2015). Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin. Oncotarget. 6(28). 25588–25601. 52 indexed citations
6.
Zeng, Yin-duo, Hai Liao, Li Zhang, et al.. (2015). Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy. Oncotarget. 6(10). 8366–8376. 93 indexed citations
7.
Hu, Pan, Jie Gao, Wei-Dong Wei, et al.. (2013). Low Expression of Tyrosine-protein Phosphatase Nonreceptor Type 12 is Associated with Lymph Node Metastasis and Poor Prognosis in Operable Triple-negative Breast Cancer. Asian Pacific Journal of Cancer Prevention. 14(1). 287–292. 19 indexed citations
8.
Li, Xing, Wei-Dong Wei, Peng Liu, et al.. (2013). Signet-ring cell carcinoma of the breast: a case report. World Journal of Surgical Oncology. 11(1). 183–183. 13 indexed citations
9.
Tang, Hailin, Yanan Kong, Lu Yang, et al.. (2013). Metastatic Axillary Lymph Node Ratio (LNR) is Prognostically Superior to pN Staging in Patients with Breast Cancer -- Results for 804 Chinese Patients from a Single Institution. Asian Pacific Journal of Cancer Prevention. 14(9). 5219–5223. 7 indexed citations
10.
Lv, Ning, et al.. (2012). Clinical Characteristics and Survival Analysis of Breast Cancer Molecular Subtypes with Hepatic Metastases. Asian Pacific Journal of Cancer Prevention. 13(10). 5081–5086. 20 indexed citations
11.
Chen, Li-kun, et al.. (2012). Triplet Platinum-based Combination Sequential Chemotherapy Improves Survival Outcome and Quality of Life of Advanced Non-small Cell Lung Cancer Patients. Asian Pacific Journal of Cancer Prevention. 13(5). 1863–1867. 13 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine J. Kennedy Breakdown of academic impact, for papers by Yaning He Breakdown of academic impact, for papers by Shin Takayama Breakdown of academic impact, for papers by Min‐Sun Jin Breakdown of academic impact, for papers by Carla Strina Breakdown of academic impact, for papers by Anne Patsouris Breakdown of academic impact, for papers by Shuiping Gao Breakdown of academic impact, for papers by C. P. Carden Breakdown of academic impact, for papers by Sarah Croessmann Breakdown of academic impact, for papers by Leighton C. Stein
Rankless by CCL
2026